Published on

Top officials of the digital health operator Done Global were arrested last week for alleged healthcare fraud that drove about $100 million worth of stimulant drugs into consumers’ hands. According to the Department of Justice press release, the CEO and the clinical leader of Done Global allegedly created a scheme to provide access to attention deficit-hyperactivity disorder (ADHD) drugs for consumers in exchange for monthly subscription fees on the telemedicine platform. The company spent millions on deceptive social media ads and arranged for the prescription of over 40 million pills. The arrests come at a time when the nation is experiencing a large-scale shortage of ADHD drugs.

Quality of care: “This DOJ action raises concerns over the ethics, quality, oversight, and liability of corporately-owned, for-profit, national pureplay telemedicine providers,” says Alan Ayers, MBA, MAcc, president of Experity Consulting and Senior Editor of JUCM.

Execs of Digital Platform Arrested for Fraudulent ADHD Prescriptions